Pdt Partners, LLC Medi Wound Ltd. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.86 - $3.24 $45,389 - $79,065	-24,403 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.01 $3,293 - $6,002	-1,497 Reduced 5.78%	24,403 $58,000
Q3 2021 Nov 15, 2021	BUY	$3.34 - $4.63 $45,090 - $62,505	13,500 Added 108.87%	25,900 $86,000
Q2 2021 Aug 16, 2021	BUY	$3.38 - $5.71 $41,912 - $70,804	12,400 New	12,400 $47,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $632M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.